Frost & Sullivans 2014 Life Sciences Outlook

Innovative Transformations and Value Creations in Life Sciences

USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

In 2013, healthcare moved towards access, transparency,  investments, and spending. In 2014, Frost & Sullivan anticipates new launches to occur across the life sciences spectrum, from preventive medicine to treating complex diseases. This market insight touches upon major events that occurred in 2013 and how 2014 is expected to shape up, including future investments, regulatory changes, and new launches. Key companies to watch are highlighted, and strategic recommendations are provided.

Table of Contents

Frost & Sullivan's 2014 Life Sciences Outlook2014 Life Sciences OutlookOverview

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.